Literature DB >> 1116868

Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.

B McLeod, P Baker, H Gewurz.   

Abstract

An activity in serum which inhibits reactive lysis has recently been shown to do so by preventing the attachment of C567 complexes to cells, and hence has been designated C567-INH. This report describes certain physiochemical characteristics of the inhibitory activity. It behaves as a heat-stable pseudoglobulin, soluble in 20 per cent Na2SO4, and having alpha1 mobility on Pevikon block electrophoresis. It is excluded from CM cellulose at pH 6-0, RSC Equals 0.007 M, is retained by an XM-100 membrane and is heterogenous on Sephadex G-200, eluting in at least two peaks. The combined active materials from the Sephadex column elute from DE-52 in at least four peaks. The mechanism of action of material from each of these four peaks is shown to involve prevention of attachment of C567 complexes to membranes, and this is shown to involve an effect on C567 complexes in solution rather than an effect on the membrane. A less dramatic effect on the lysis of EC567 by limited quanities of C8 and C9 can be demonstrated. Haemolytic studies using cell-bound C567 suggest that the interaction of C567-INH with C567 involves a loose reversible association. It is therefore postulated that C567-INH inhibits reactive lysis primarily by reversibly associating with the nascent C567 complex in solution, increasing its bulk and decreasing its diffusion capacity so that it is unable to reach a cell membrane before its haemolytic potential decays.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116868      PMCID: PMC1445758     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9.

Authors:  J N Goldman; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

2.  Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  Immunology       Date:  1967-07       Impact factor: 7.397

3.  Studies on the inhibition of C56 initiated lysis (reactive lysis). I. Description of the phenomenon and methods of assay.

Authors:  B McLeod; P Baker; H Gewurz
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

4.  The alternate complement pathway in cell damage: antibody-mediated cytolysis of erythrocytes and nucleated cells.

Authors:  J E May; I Green; M M Frank
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

5.  Interactions between human C5, C6, and C7 and their functional significance in complement-dependent cytolysis.

Authors:  C M Arroyave; H J Müller-Eberhard
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

6.  Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.

Authors:  S M Koethe; K F Austen; I Gigli
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

7.  Chemotactic factor inactivator in normal human serum.

Authors:  J L Berenberg; P A Ward
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

8.  Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

Authors:  P J Lachmann; R A Thompson
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

9.  The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution.

Authors:  W P Kolb; J A Haxby; C M Arroyave; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

10.  Lysis of erythrocytes by complement in the absence of antibody.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  10 in total

1.  Binding of the complement intermediate C56 to zymosan in acute phase human sera.

Authors:  P J Baker; L G Rubin; T F Lint; B C McLeod; H Gewurz
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway.

Authors:  A Martin; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

Review 3.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

4.  Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.

Authors:  N Tamura; A S Baba
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

5.  Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.

Authors:  B McLeod; T F Lint; P Baker; C Behrends; H Gewurz
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

6.  Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones.

Authors:  P J Baker; T F Lint; J Siegel; M W Kies; H Gewurz
Journal:  Immunology       Date:  1976-04       Impact factor: 7.397

7.  A reason for the cytolytic inefficiency of murine serum.

Authors:  F Sassi; F Hugo; M Muhly; A Khaled; S Bhakdi
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

8.  Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.

Authors:  C J Parker; T Wiedmer; P J Sims; W F Rosse
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

9.  Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.

Authors:  B McLeod; P Baker; C Behrends; H Gewurz
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

10.  Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.

Authors:  S I Rosenfeld; C H Packman; J P Leddy
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.